HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $60

HC Wainwright & Co. analyst Patrick R. Trucchio has maintained a Buy rating on Alto Neuroscience (NYSE: ANRO) and raised the price target from $55 to $60. This adjustment reflects a positive outlook for the company's performance.